Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer

Despite the recent advances in the biological understanding of breast cancer (BC), chemotherapy still represents a key component in the armamentarium for this disease. Different agents are available as mono-chemotherapy options in patients with locally advanced or metastatic BC (MBC) who progress af...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorusso, Vito, Latorre, Agnese, Giotta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719522/
https://www.ncbi.nlm.nih.gov/pubmed/33312203
http://dx.doi.org/10.1155/2020/9645294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719522/
https://www.ncbi.nlm.nih.gov/pubmed/33312203
http://dx.doi.org/10.1155/2020/9645294

Ejemplares similares